New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2012
13:13 EDTMYGNMyriad Genetics has little risk from Prometheus ruling, says Cowen
Cowen said patent consultants see little risk to Myriad from the Prometheus Supreme Court decision ruling. Shares are Neutral rated.
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2016
08:22 EDTMYGNMyriad Genetics management to meet with JPMorgan
Subscribe for More Information
February 7, 2016
14:27 EDTMYGNMyriad Genetics management to meet with Stephens
Meeting to be held in Boston on February 9 hosted by Stephens.
February 2, 2016
19:22 EDTMYGNOn The Fly: After Hours Movers
UP AFTER EARNINGS: Boot Barn (BOOT), up 16.5%... Wabash National (WNC), up 9.7%... Oclaro (OCLR), up 6.8%... Myriad Genetics (MYGN), up 8%... Ultimate Software Group (ULTI), up 6.2%... Natural Health (NHTC), up 6.2%... Edwards Lifesciences (EW), up 6.2%... Viavi Solutions (VIAV), up 2.4%... Gilead Sciences (GILD), up just under 1%. DOWN AFTER EARNINGS: Match Group (MTCH), down 7.3%... Yahoo (YHOO), down 1.2%... Chipotle (CMG), down 7.1%. ALSO LOWER: Barnes & Noble (BKS), down 2.4% after General Growth (GGP) CEO Sandeep Mathrani announced that Amazon (AMZN) is going to open 300-400 brick-and-mortar bookstores.
16:10 EDTMYGNMyriad Genetics sees FY16 EPS $1.63-$1.68, consensus $1.64
Sees FY16 revenue $750-$770M , consensus $759.25M.
16:09 EDTMYGNMyriad Genetics sees Q3 EPS 37c-39c, consensus 40c
Subscribe for More Information
16:07 EDTMYGNMyriad Genetics reports Q2 EPS 45c, consensus 41c
Subscribe for More Information
14:32 EDTMYGNNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use